Tracy M. Downs, MD Print Friendly PageFaculty, University of Wisconsin School of Medicine and Public Health
Dr. Downs is a urologic surgeon and fellowship-trained specialist in urologic oncology. He performs specialized surgery for complex cancers of the genitourinary tract, including robotic cystectomy and other minimally invasive procedures. He has a special interest in the treatment of bladder cancer, and directs the UW Bladder Cancer and Intravescial Therapy Programs.
|Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.|
UW School of Medicine and Public Health
|Department of Urology|
Professional Certifications and Education
Urologic Oncology, University of California-San Francisco, San Francisco, CA, 2003
Brigham and Women's Hospital, Boston, MA
University of California, San Diego School of Medicine, La Jolla, CA, 1993
Our doctors provide a wide range of services. The following list represents some, but not all, of the procedures offered by this physician.
Dr. Downs has a joint appointment with the UW Carbone Cancer Center where his translational research focuses on discovery of molecular and urinary biomarkers for bladder cancer and his clinical research focuses on developing new therapies for genitourinary cancers.
Potretzke A Hillman L Wong K Shi F Brower R Mai S Cetnar JP Abel EJ Downs TM .
NLR is predictive of upstaging at the time of radical cystectomy for patients with urothelial carcinoma of the bladder. Urol Oncol. 2014 Jul;32(5):631-6
[PubMed ID: 24629498]
Downs TM .
Reply. Urology. 2014 Jun;83(6):1216
[PubMed ID: 24751190]
Downs TM Rayford W Davis DE Nakada SY .
Richard Francis Jones--opening doors and diversifying the urologic workforce: a pioneer in the training of African urologic surgeons in North America. Urology. 2014 Jun;83(6):1213-6
[PubMed ID: 24751189]
Abel EJ Bauman TM Weiker M Shi F Downs TM Jarrard DF Huang W .
Analysis and validation of tissue biomarkers for renal cell carcinoma using automated high-throughput evaluation of protein expression. Hum Pathol. 2014 May;45(5):1092-9
[PubMed ID: 24746216]
Shapiro DD Potretzke A Downs TM .
Leukemoid reaction: a rare paraneoplastic syndrome in bladder cancer associated with a grave prognosis. Urology. 2014 Feb;83(2):274-7
[PubMed ID: 24044914]
Abel EJ Wong K Sado M Leverson GE Patel SR Downs TM Jarrard DF .
Surgical operative time increases the risk of deep venous thrombosis and pulmonary embolism in robotic prostatectomy. JSLS. 2014;18(2):282-7
[PubMed ID: 24960494]
Truong M Slezak JA Lin CP Iremashvili V Sado M Razmaria AA Leverson G Soloway MS Eggener SE Abel EJ Downs TM Jarrard DF .
Development and multi-institutional validation of an upgrading risk tool for Gleason 6 prostate cancer. Cancer. 2013 Nov 15;119(22):3992-4002
[PubMed ID: 24006289]
Downs TM .
Editorial comment. Urology. 2013 Jun;81(6):1278
[PubMed ID: 23528914]
Cetnar JP Hampton JM Williamson AA Downs T Wang D Owen JB Crouse B Jones N Wilson JF Trentham-Dietz A .
Place of residence and primary treatment of prostate cancer: examining trends in rural and nonrural areas in Wisconsin. Urology. 2013 Mar;81(3):540-6
[PubMed ID: 23332992]
Potretzke AM Wong KS Downs TM .
Intravesical Foreign Body via a Vesicoperineal Fistula. Case Rep Urol. 2013;2013:659582
[PubMed ID: 23653880]
Ewald JA Downs TM Cetnar JP Ricke WA .
Expression microarray meta-analysis identifies genes associated with Ras/MAPK and related pathways in progression of muscle-invasive bladder transition cell carcinoma. PLoS One. 2013;8(2):e55414
[PubMed ID: 23383328]
Woldrich JM Silberstein JL Saltzstein SL Derweesh IH Downs TM .
Penile Kaposis sarcoma in the state of California. Can J Urol. 2012 Apr;19(2):6178-82
[PubMed ID: 22512961]
Bazzi WM Raheem OA Stroup SP Kane CJ Derweesh IH Downs TM .
Partial orchiectomy and testis intratubular germ cell neoplasia: World literature review. Urol Ann. 2011 Sep;3(3):115-8
[PubMed ID: 21976922]
Downs TM Burton DW Araiza FL Hastings RH Deftos LJ .
PTHrP stimulates prostate cancer cell growth and upregulates aldo-keto reductase 1C3. Cancer Lett. 2011 Jul 1;306(1):52-9
[PubMed ID: 21444150]
Silberstein JL Millard F Mehrazin R Kopp R Bazzi W DiBlasio CJ Patterson AL Downs TM Yunus F Kane CJ Derweesh IH .
Feasibility and efficacy of neoadjuvant sunitinib before nephron-sparing surgery. BJU Int. 2010 Nov;106(9):1270-6
[PubMed ID: 20394613]
Derweesh IH Silberstein JL Bazzi W Kopp R Downs TM Kane CJ .
Laparo-endoscopic single-site surgery for radical and cytoreductive nephrectomy, renal vein thrombectomy, and partial nephrectomy: a prospective pilot evaluation. Diagn Ther Endosc. 2010;2010:107482
[PubMed ID: 20631830]
Downs TM Schultzel M Shi H Sanders C Tahir Z Sadler GR .
Renal cell carcinoma: risk assessment and prognostic factors for newly diagnosed patients. Crit Rev Oncol Hematol. 2009 Apr;70(1):59-70
[PubMed ID: 18993080]
Orom H Penner LA West BT Downs TM Rayford W Underwood W .
Personality predicts prostate cancer treatment decision-making difficulty and satisfaction. Psychooncology. 2009 Mar;18(3):290-9
[PubMed ID: 18821530]
Lu Q Nunez E Lin C Christensen K Downs T Carson DA Wang-Rodriguez J Liu YT .
A sensitive array-based assay for identifying multiple TMPRSS2:ERG fusion gene variants. Nucleic Acids Res. 2008 Nov;36(20):e130
[PubMed ID: 18794177]
Saxe GA Major JM Westerberg L Khandrika S Downs TM .
Biological mediators of effect of diet and stress reduction on prostate cancer. Integr Cancer Ther. 2008 Sep;7(3):130-8
[PubMed ID: 18815144]